| 000 | 01793 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515063949.0 | ||
| 264 | 0 | _c20070703 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a0934-0874 | ||
| 024 | 7 |
_a10.1111/j.1432-2277.2007.00477.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGossmann, Jan | |
| 245 | 0 | 0 |
_aAbrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _cJun 2007 |
||
| 300 |
_a558-62 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerulosclerosis, Focal Segmental _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xetiology |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xcomplications |
| 650 | 0 | 4 |
_aProteinuria _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 | _aReoperation |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aScheuermann, Ernst-Heinrich | |
| 700 | 1 | _aPorubsky, Stefan | |
| 700 | 1 | _aKachel, Heinz-Georg | |
| 700 | 1 | _aGeiger, Helmut | |
| 700 | 1 | _aHauser, Ingeborg A | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 20 _gno. 6 _gp. 558-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1432-2277.2007.00477.x _zAvailable from publisher's website |
| 999 |
_c16983712 _d16983712 |
||